Thursday, September 23, 2004

In the news

A study in the September issue of Brain looks at damage to dopamine receptors, pointing toward potential new ways of treating or preventing HIV dementia. See these stories for more information:

Researchers at Washington University studied the effect of ritonivir in preventing osteoporesis in HIV positive men. Their results are published in The Journal of Clinical Investigation. For more information, see the following press release:

New CDC regulations are likely to affect HIV prevention by muddying the discussion of condom use and requiring another (chilling) layer of review for explicit prevention messages. See these news stories for more information.

No comments: